Fatal Acinetobacter baumanii pneumonia diagnosed at autopsy in a patient with end-stage renal disease: A case report and review

Pathology Case Reviews

Volumn 12, Issue 3, 2007, Pages 122-125

  Mourtzinos, Nikki ^a   Schwartz, Arnold M ^a   Orenstein, Jan M ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acinetobacter; End stage renal disease

Indexed keywords

ANTIBIOTIC AGENT;

ACINETOBACTER BAUMANNII; ADULT; ALLERGIC VASCULITIS; AUTOPSY; BLOOD CULTURE; BRONCHOPNEUMONIA; CASE REPORT; DYSPNEA; EFFUSION; GRAM NEGATIVE BACTERIUM; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; LUNG ABSCESS; LUNG EDEMA; LUNG INSUFFICIENCY; LUNG PARENCHYMA; MALE; MORTALITY; NECROTIZING ARTERITIS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEPSIS; THORAX PAIN;

EID: 34248196533     PISSN: 10829784     EISSN: 15334015     Source Type: Journal    
DOI: 10.1097/PCR.0b013e31805d0b6e     Document Type: Review

References (23)

1. US Renal Data System. USRDS 2004 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2004.
2. Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest. 2001;120:1883-1887.
3. Falguera M, Pifarre R, Martin A, et al. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest. 2005;128:3233-3239.
4. D'Agata EM, Mount DB, Thayer V, et al. Hospital-acquired infections among chronic hemodialysis patients. Am J Kidney Dis. 2000;35:1083-1088.
5. Berman SJ, Johnson EW, Nakatsu C, et al. Burden of infection in patients with end-stage renal disease requiring long-term dialysis. Clin Infec Dis. 2004;39:1747-1753.
6. Johnson JB, Venugopal AA, et al. Emergence of community-associated methicillin-resistant staphylococcus aureus infection among patients with end-stage renal disease. Infect Control Hosp Epidemiol. 2006;27:1057-1062.
7. D'Agata EMC. Antimicrobial-resistant, gram-positive bacteria among patients undergoing chronic hemodialysis. Clin Infec Dis. 2002;35:1212-1218.
8. Salzer W. Antimicrobial-resistant gram-positive bacteria in PD peritonitis and the newer antibiotics used to treat them. Perit Dial Int. 2005;25:313-319.
9. Jaber BL. Bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int. 2005;67:2508-2519.
10. Vanholder R, Ringoir S. Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol. 1993;3:1541-1554.
11. Cendoroglo M, Jaber BL, Balakrishnan VS, et al. Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol. 1999;10:93-100.
12. Sardenberg C, Suassuna P, Andreoli MC, et al. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function. Nephro Dial Transpl. 2006;21:160-165.
13. Gavelli G, Zompatori M. Thoracic complications in uremic patients and in patients undergoing dialytic treatment: state of the art. Eur Radiol. 1997;7:708-717.
14. Slinin Y, Foley RN, Collins RJ. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int. 2006;70:1135-1141.
15. Koziel H, Koziel MJ. Pulmonary complications of diabetes mellitus: pneumonia. Infect Dis Clin North Am. 1995;9:65-96.
16. Shorr AF, Susla GM, O'Grady NP. Pulmonary infiltrates in the non-HIV-infected immunocompromised patient. Chest. 2004;125:260-271.
17. Knirsch CA, Jakon K, Schoonmaker MS, et al. An outbreak of Legionella pneumonia in transplant patients: evaluation, molecular epidemiology, and control. Am J Med. 2000;108:290-295.
18. Elting LS, Bodey GP, Keefe BH. Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors. Clin Infect Dis. 1992;14:1201-1207.
19. Allen D, Hartman B. Acinetobacter species. In: Mandell GL, Bennett JE, and Dolin R, eds. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone; 2000:2339-2344.
20. Winn Washington C, et al. In: Koneman's Color Atlas and Textbook of Diagnostic Microbiology. Philadelphia: Lippincott Williams & Wilkins; 2006:353-355.
21. Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006;43(Suppl 2):S57-S61.
22. Navon-Venezia S, Ben-Ami R, Carmeli Y. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis. 2005;18:306-313.
23. King DR, Namias N, Pizano LR, et al. An unusual cause of septicemia and death in a burn patient: discussion and review. J Burn Care Rehabil. 2005;26:502-504.